MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2023 International Congress

August 27-31, 2023. Copenhagen, Denmark.

View by Title View Categories
Jump to:  View All • a [b] c d e f g h i j k l m n o p q r s t u v w x y z
  • Basal ganglia shape in de novo Parkinson’s disease patients can predict the onset of Levodopa Induced Dyskinesias

    S. Shukla, M. Patnaik, A. Kumar, N. Thirugnanasambandam, S. Tinaz (Mumbai, India)

  • Baseline characteristics for patients with multiple system atrophy entering a randomized, controlled study of the anti-α-synuclein monoclonal antibody Lu AF82422

    W. Singer, A. Takeda, L. Kjærsgaard, J. Wiedemann, A. Berger, A. Varrone, A. Bidani, D. Meulien (Rochester, USA)

  • Baseline fluid biomarkers in a phase 2 clinical trial in Parkinson’s Disease

    T. Kustermann, G. Pagano, H. Svoboda, T. Nikolcheva, K. Taylor (Basel, Switzerland)

  • Be aware of Involuntary Emotional Expressive Disorder: a neurological syndrome, not a mood disorder

    V. Balasubramaniam, L. Baytieh (WOLLONGONG, Australia)

  • Benefit of multiple incobotulinumtoxinA injections for pain reduction in adults with cervical dystonia: an analysis of pooled data

    A. Albanese, J. Wissel, W. Jost, A. Castagna, M. Althaus, G. Comes, A. Scheschonka, M. Vacchelli, H. Jinnah (Rozzano, Italy)

  • Benefits of Physician-Pharmacist Collaboration on Patient Outcomes in Parkinson’s Disease and Movement Disorders Clinic

    P. Techa-Angkoon, Y. Pitakpatapee, W. Saengphatrachai, P. Srivanitchapoom, T. Suansanae (Bangkok, Thailand)

  • Beta is jumping the queue: Temporal overlap of beta desynchronization and synchronization during rapid movement changes

    L. Winkler, M. Butz, A. Sharma, J. Vesper, A. Schnitzler, P. Fischer, J. Hirschmann (Düsseldorf, Germany)

  • Beta LFP Power Change After Levodopa Intake in Parkinson’s Disease Patients with Chronic Sensing-Enabled DBS Systems

    M. de Neeling, M. Stam, B. van Wijk, J. Anso, R. Raike, P. Schuurman, R. de Bie, A. Buijink, M. Beudel (Amsterdam, Netherlands)

  • Beyond Parkinson´s disease and synucleinopathies: unexpected identification of prodromal corticobasal syndrome by the updated MDS research criteria for prodromal PD

    K. Kulcsarova, E. Feketeova, J. Ventosa, M. Maretta, A. Lackova, M. Ostrozovicova, N. Lesko, M. Bekeová, P. Christová, S. Muranska, S. Mrazova, Z. Gdovinova, M. Skorvanek (Kosice, Slovakia)

  • Bilateral Globus Pallidus Internus Deep Brain Stimulation for Cervical Dystonia: Effects on Motor and Non-Motor Symptoms within 5 Years Follow Up

    A. Khanom, P. Franceschini, S. Lane, J. Osman-Farah, A. Macerollo (Liverpool, United Kingdom)

  • Bilateral Globus Pallidus Internus Deep Brain Stimulation in Progressive Dystonia in Mohr-Tranebjaerg Syndrome: Case Report and Review

    L. Barcelos, M. Marinho, T. Capato, V. Borges, H. Ferraz (SAO PAULO, Brazil)

  • Bilateral staged MR-guided focused ultrasound thalamotomy for Essential Tremor: one-year follow-up results

    S. Mahendran, F. Büchele, M. Uhl, C. Freudinger, M. Oertel, C. Baumann, L. Stieglitz (Zurich, Switzerland)

  • Bilateral staged MRI-guided focused ultrasound subthalamotomy for Parkinson’s disease

    E. Natera-Villalba, R. Martínez-Fernández, R. Rodríguez-Rojas, M. Del álamo, JA. Pineda-Pardo, M. Matarazzo, A. Ruiz-Yanzi, C. Gasca-Salas, P. Guida, T. Jiménez-Castellanos, JA. Obeso (Madrid, Spain)

  • Bilateral subthalamic nucleus deep brain stimulation in Parkinson’s disease: preoperative predictors of speech worsening

    F. Cavallieri, F. Bove, A. Zampogna, A. Castrioto, S. Meoni, A. Gessani, E. Schmitt, A. Bichon, E. Lhommée, P. Pélissier, A. Kistner, E. Chevrier, F. Valzania, E. Seigneuret, S. Pinto, S. Chabardès, V. Fraix, E. Moro (Reggio Emilia, Italy)

  • Billiards-related tremor: a form of task-specific tremor

    T. Thammongkolchai, P. Termsarasab (Bangkok, Thailand)

  • blepharoplasty yes or not? a single-centre study on the influence of blepharoplasty on the treatment with botulinum toxin injections.

    A. Trinchillo, N. Cuomo, F. Iorillo, G. de Joanna, F. Habetswallner, M. Esposito (Giugliano in Campania, Italy)

  • Blood derived α-synuclein seeding in the course of Parkinson’s Disease

    A. Kluge, E. Schaeffer, K. Brockmann, C. Schulte, C. Deuschle, J. Bunk, W. Maetzler, D. Berg (Kiel, Germany)

  • Blood NfL can track progression in multiple system atrophy

    V. Chelban, A. Perez-Soriano, C. Wilke, A. Foubert-Samier, N. Vijiaratnam, T. Guo, E. Jabbari, K. Senkevich, B. Laurens, P. Péran, O. Rascol, L. Schöls, C. Kobylecki, M. Hu, J. Rowe, T. Foltynie, N. Wood, A. Heslegrave, H. Zetterberg, M. Bocchetta, J. Rohrer, M. Marti, M. Synofzik, H. Morris, W. Meissner, H. Houlden (London, United Kingdom)

  • Blood Pressure Monitoring in Multiple System Atrophy: Focused on Nocturnal Dipping Pattern

    I. Jeremia, A. Tiksnadi, D. Tunjungsari (DKI Jakarta, Indonesia)

  • Bone Health in Parkinson’s Disease

    E. Killeen, C. Gallagher, A. Mcdonough (Dublin, Ireland)

  • Botulinum neurotoxin in FXTAS-related tremor: a “successful” case report

    AT. Cimmino, P. Sanginario, AR. Bentivoglio, P. Calabresi, M. Petracca, G. Di Lazzaro (Rome, Italy)

  • Botulinum toxin injections for lingual protrusion dystonia: a review of the muscle target and dosage

    A. Duarte, H. Ghizoni Teive (Curitiba, Brazil)

  • Botulinum toxin treatment for focal dystonia in a Tunisian cohort

    M. Jamoussi, H. Benrhouma, M. Ben Hafsa, T. Ben Younes, Z. Miladi, H. Klaa, I. Kraoua, N. Gouider Khouja, I. Ben Youssef (Tunis, Tunisia)

  • Botulinum toxin-A in head and upper extremities tremor. A hand-made option

    H. Shehata, M. Shehata, M. Basheer, A. Elmazny, N. Shalaby (Cairo, Egypt)

  • Bowel symptoms and management practices in Parkinson’s disease and related conditions: results from the PRIME-UK study.

    C. Thomas, E. Tenison, K. Lloyd, M. Smith, Y. Ben-Shlomo, E. Henderson (Gloucestershire, United Kingdom)

  • Bradykinesia in Patients with Cervical Dystonia: Objective Assessment with Optical Sensor

    Z. Kosutzka, B. Gastanova, P. Matejicka, S. Kajan, P. Valkovic, M. Minar (Bratislava, Slovakia)

  • Brain FDG-PET-MRI for early diagnosis of corticobasal syndrome

    I. Guan, C. Stahl, K. Astudillo, T. Shepherd, S. Frucht, G. Riboldi (New York, USA)

  • Brain first-body first: is the dat-scan useful?

    G. Bellini, G. Palermo, D. Frosini, E. Benevento, E. Del Prete, M G. Tedeschi, S. Visinoni, A. Francesconi, R. Ceravolo (Pisa, Italy)

  • Brain functional state mapping in resting state and network alteration in Spinocerebellar Ataxia Type 2 in comparison with healthy controls

    P. Pankaj, S. Kumaran, A. Srivastava, A. Garg, R. Agarwal, A. Nehra (New Delhi, India)

  • Brain metabolic response of primary sensory cortex transcranial magnetic stimulation in cervical dystonia

    A. Kokkonen, DT. Corp, J. Joutsa (Turku, Finland)

  • Brain metabolism associated with clinical feature in patients with multiple system atrophy

    S. Lee, S. Jo, J. Lee, S. Chung (Seoul, Republic of Korea)

  • Brain MRI volumetry analysis for patients with Parkinson’s disease suffering from REM sleep behavior disorder: a pilot study

    T. Vanagas, G. Paulekiene, A. Radziunas, R. Balnyte, E. Pajediene, E. Paulekas (Kaunas, Lithuania)

  • Brain-behavior quantification and synchronization to drive closed-loop deep brain stimulation

    A. Gunduz, D. Johnson, M. Okun, K. Foote (Gainesville, USA)

  • Breast carcinoma presenting with anti-amphiphysin antibody-associated stiff-limb syndrome

    AM. Dy Closas, AH. Tan, KJ. Goh, JP. Schee, MH. See, SML. Tai, SY. Lim (Kuala Lumpur, Philippines)

  • Bridging the Gap between Statistical significance and Clinical Relevance: A Systematic Review of Minimum clinically important difference (MCID) thresholds of scales reported in trials of Movement Disorders

    B. Mishra, S. Pachipala, R. Rajan, A. Agarwal, MVP. Srivastava, N. Nilima, VY. Vishnu (Delhi, India)

  • Building a consensus conceptual model of meaningful symptoms and impacts in early Parkinson’s disease

    J. Adams, J. Mammen, C. Kopil, Y. Xiao, D. Stephenson, T. Simuni (Rochester, USA)

  • Building and evaluating a speech biomarker from 2-seconds sustained phonation to detect and monitor Parkinson’s disease

    J. Tröger, L. Schwed, E. Baykara, N. Linz, J. Orozco-Arroyave (Saarbrücken, Germany)

  • Burden and management of tardive dyskinesia (TD): a cross-sectional international survey study to assess the perceptions and experiences of patients with TD

    R. Ribalov, A. Yaari, A. Peyser Levin, A. Yang, D. Horchi, E. Berjonneau, P. Le Calvé, M. Tian, S. Reshef, S. Reed (Tel-Aviv-Yafo, Israel)

Jump to:  View All • a [b] c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley